loading
전일 마감가:
$51.30
열려 있는:
$51.09
하루 거래량:
63,863
Relative Volume:
0.46
시가총액:
$598.88M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.37%
1개월 성능:
+39.27%
6개월 성능:
+187.27%
1년 성능:
+0.00%
1일 변동 폭
Value
$49.81
$54.15
1주일 범위
Value
$49.13
$57.19
52주 변동 폭
Value
$11.17
$57.19

Palvella Therapeutics Inc Stock (PVLA) Company Profile

Name
명칭
Palvella Therapeutics Inc
Name
전화
(484) 253-1461
Name
주소
125 STRAFFORD AVE, WAYNE
Name
직원
14
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
PVLA's Discussions on Twitter

PVLA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PVLA
Palvella Therapeutics Inc
54.15 567.36M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-06 개시 Raymond James Outperform
2025-07-21 개시 Truist Buy
2025-04-09 개시 Chardan Capital Markets Buy
2025-03-26 개시 Stifel Buy
2025-03-07 개시 Scotiabank Sector Outperform
2025-02-20 개시 Canaccord Genuity Buy
2025-02-05 개시 TD Cowen Buy
2024-12-26 개시 H.C. Wainwright Buy
2024-12-18 개시 Cantor Fitzgerald Overweight
2020-03-13 업그레이드 Robert W. Baird Neutral → Outperform
2019-07-30 다운그레이드 Robert W. Baird Outperform → Neutral
2019-05-14 개시 Robert W. Baird Outperform
2018-03-19 개시 Evercore ISI Outperform
2018-03-19 개시 Jefferies Buy
2018-01-16 재확인 H.C. Wainwright Buy
2017-05-30 개시 Rodman & Renshaw Buy
2016-08-05 재개 ROTH Capital Buy
2015-08-12 개시 JMP Securities Mkt Outperform
2015-07-27 개시 Oppenheimer Outperform
2015-07-22 개시 ROTH Capital Buy
모두보기

Palvella Therapeutics Inc 주식(PVLA)의 최신 뉴스

pulisher
Aug 31, 2025

What high frequency data says about Palvella Therapeutics Inc.Options Play & Real-Time Market Sentiment Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

News impact scoring models applied to Palvella Therapeutics IncBreakout Watch & Risk Controlled Stock Pick Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Palvella Therapeutics Inc. stock poised for growthMarket Risk Analysis & Growth Oriented Trade Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

News impact scoring models applied to Palvella Therapeutics Inc.Earnings Overview Report & Safe Investment Capital Preservation Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using data models to predict Palvella Therapeutics Inc. stock movementRate Cut & AI Enhanced Trading Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Palvella Therapeutics Inc. showing signs of accumulationQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using flow based indicators on Palvella Therapeutics Inc.July 2025 Rallies & Real-Time Volume Analysis - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using RSI to spot recovery in Palvella Therapeutics Inc.Trade Risk Report & Expert Approved Momentum Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Applying Elliott Wave Theory to Palvella Therapeutics Inc.Global Markets & Long-Term Safe Investment Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Palvella Therapeutics Inc. stock entering bullish territory2025 EndofYear Setup & High Return Stock Watch Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using portfolio simulators with Palvella Therapeutics Inc. includedM&A Rumor & Real-Time Volume Trigger Notifications - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Palvella Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Action & Verified Entry Point Detection - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Quantitative breakdown of Palvella Therapeutics Inc. recent moveWeekly Gains Summary & Detailed Earnings Play Strategies - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Palvella Therapeutics Inc. Shows Risk Reward Favoring Upside2025 Biggest Moves & Safe Capital Growth Tips - beatles.ru

Aug 30, 2025
pulisher
Aug 30, 2025

What institutional flow reveals about Palvella Therapeutics Inc.Volume Spike & Free Risk Controlled Daily Trade Plans - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Will Palvella Therapeutics Inc. stock recover after recent dropRecession Risk & Community Consensus Picks - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Recovery Signals Appearing in Palvella Therapeutics Inc. Charts getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 29, 2025
pulisher
Aug 29, 2025

Will Palvella Therapeutics Inc. benefit from macro trendsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Ranking Palvella Therapeutics Inc. among high performing stocks via toolsWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

How hedge fund analytics apply to Palvella Therapeutics Inc. stockEarnings Miss & Breakout Confirmation Alerts - Newser

Aug 29, 2025

Palvella Therapeutics Inc (PVLA) 재무 분석

Palvella Therapeutics Inc (PVLA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
자본화:     |  볼륨(24시간):